Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Income towards Parent Company (2013 - 2018)

Updated

Altamira Therapeutics (CYTOF) reported Income towards Parent Company of -$6.7 million for FY2019, compared with -$11.55 million in FY2018.

Analysis

Altamira Therapeutics (CYTOF) Income towards Parent Company (2013 - 2018) Analysis & Trends

Dating back to FY2015, Altamira Therapeutics' Income towards Parent Company record includes 5 years.

  • The FY2019 figure ranks as the highest annual Income towards Parent Company in data going back to FY2015.
  • According to Business Quant data, Income towards Parent Company came in at -$11.55 million in FY2018, -$24.8 million in FY2017, -$31.14 million in FY2016 and -$30.89 million in FY2015.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.71 Mn
Sep 30, 2018 -3.03 Mn
Jun 30, 2018 -3.13 Mn
Mar 31, 2018 -1.84 Mn
Dec 31, 2017 -4.65 Mn
Sep 30, 2017 -6.25 Mn
Jun 30, 2017 -5.49 Mn
Mar 31, 2017 -8.37 Mn
Dec 31, 2016 -5.57 Mn
Sep 30, 2016 -8.09 Mn
Jun 30, 2016 -8.69 Mn
Mar 31, 2016 -8.96 Mn
Dec 31, 2015 -5.54 Mn
Sep 30, 2015 -5.41 Mn
Jun 30, 2015 -11.63 Mn
Mar 31, 2015 -8.46 Mn
Dec 31, 2014 -4.12 Mn
Sep 30, 2014 -3.68 Mn
Jun 30, 2014 -6.59 Mn
Mar 31, 2014 -6.56 Mn
API Access

Altamira Therapeutics Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CYTOF&period=max&api_key=YOUR_API_KEY